154 related articles for article (PubMed ID: 16149602)
1. [CA546, CA602].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():647-50. PubMed ID: 16149602
[No Abstract] [Full Text] [Related]
2. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
[No Abstract] [Full Text] [Related]
3. [GAT (galactosyltransferase associated with tumor)].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():726-9. PubMed ID: 16149624
[No Abstract] [Full Text] [Related]
4. [CA50].
Kawabe T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():645-6. PubMed ID: 16149601
[No Abstract] [Full Text] [Related]
5. [CA546, CA602].
Yamashita H; Kataoka F; Aoki DA
Nihon Rinsho; 2010 Jul; 68 Suppl 7():688-90. PubMed ID: 20960852
[No Abstract] [Full Text] [Related]
6. [CA546, CA602].
Nozawa S; Fukuchi T
Nihon Rinsho; 1999 Dec; 57 Suppl():470-3. PubMed ID: 10778167
[No Abstract] [Full Text] [Related]
7. [NCC-ST-439].
Sugano K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
[No Abstract] [Full Text] [Related]
8. [CA125].
Kuzuya K; Kuwabara M; Ariyoshi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():637-41. PubMed ID: 16149599
[No Abstract] [Full Text] [Related]
9. [2-->6 Sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
[No Abstract] [Full Text] [Related]
10. [KMO1].
Kamigaki T; Kuroda Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():691-3. PubMed ID: 16149613
[No Abstract] [Full Text] [Related]
11. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
12. [Detection of CA 125 in the serum and tissue of patients with ovarian neoplasms].
Kristen P; Beier HJ; Kaesemann H; Caffier H
Gynakol Rundsch; 1989; 29 Suppl 2():358-60. PubMed ID: 2693257
[No Abstract] [Full Text] [Related]
13. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
[TBL] [Abstract][Full Text] [Related]
14. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
15. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Koike T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
[No Abstract] [Full Text] [Related]
16. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
Ito K; Udagawa Y; Nozawa S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
[TBL] [Abstract][Full Text] [Related]
17. [Gamma-seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
[No Abstract] [Full Text] [Related]
18. [Applications of tumor markers to the screening of endometrial and ovarian cancers].
Nozawa S; Takamatsu K; Tsukazaki K; Udagawa Y
Nihon Rinsho; 1996 Jun; 54(6):1665-73. PubMed ID: 8691627
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoembryonic antigen (CEA)].
Kinugasa T; Kuroki M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
[No Abstract] [Full Text] [Related]
20. [Squamous cell carcinoma antigen].
Nawata S; Sugino N; Kato H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
[No Abstract] [Full Text] [Related]
[Next] [New Search]